New Jersey biotech plans for tiny IPO; Vir gets $10M Gates Foundation grant for HIV vaccine
Chromocell Therapeutics, based in North Brunswick, New Jersey, plans to go public, according to an SEC filing.
According to its LinkedIn …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
